×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [33]
中国医学科学院 北... [15]
合肥物质科学研究院 [11]
西安交通大学 [10]
上海中医药大学 [10]
山东大学 [8]
更多...
内容类型
期刊论文 [119]
会议论文 [13]
图书章节 [1]
学位论文 [1]
发表日期
2022 [3]
2021 [6]
2020 [2]
2019 [14]
2018 [21]
2017 [9]
更多...
学科主题
Endocrinol... [1]
agricultur... [1]
chemistry,... [1]
food scien... [1]
物理化学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共134条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Leiomyomatosis peritonealis disseminata with low-grade malignant change: A case report
期刊论文
MEDICINE, 2022, 卷号: 101
作者:
Ye, Zhongxue
;
Chen, Lu
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/22
case report
laparoscopic myomectomy
leiomyomatosis peritonealis disseminata
low potential malignant
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
期刊论文
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 卷号: 21
作者:
Chen, Keyu
;
Wu, Jiayi
;
Fang, Ziru
;
Shao, Xiying
;
Wang, Xiaojia
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/22
early-stage breast cancer
genomic expression profiles
Oncotype DX
MammaPrint
RecurIndex
prediction tools
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Shen, Xia-Bo
;
Wu, Jia-Yi
;
Chen, Ke-Yu
;
Fang, Zi-Ru
;
Li, Guang-Liang
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2022/12/23
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Shen, Xia-Bo
;
Li, Guang-Liang
;
Zheng, Ya-Bing
;
Chen, Zhan-Hong
;
Cao, Wen-Ming
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2021/11/01
Advanced breast cancer (ABC)
aromatase inhibitors (AIs)
everolimus (EVE)
fulvestrant (FUL)
retrospective study
Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Shen, Xia-Bo
;
Li, Guang-Liang
;
Zheng, Ya-Bing
;
Chen, Zhan-Hong
;
Cao, Wen-Ming
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Shao, Xiying
;
Zheng, Yabing
;
Cao, Wenming
;
Shen, Xiabo
;
Li, Guangliang
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2021/06/15
Ki67
progesterone receptor
palbociclib
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden
期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:
Wang, Rong
;
Yang, Yuchen
;
Ye, Wei-Wu
;
Xiang, Jianxing
;
Chen, Songan
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2021/04/26
breast cancer
immunotherapy
biomarker
TMB
NGS
molecular monitoring
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer
期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:
Huang, Jian
;
Shao, Xiying
;
Cai, Li
;
Shi, Yanxia
;
Chen, Zhanhong
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2021/04/26
A narrative review of risk factors and interventions for cancer-related cognitive impairment
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Bai, Lu
;
Yu, Enyan
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/04/26
Cancer
cognitive impairment
risk factors
treatment
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Yang, Zi-yan
;
Huang, Jia-huan
;
Chen, Bo
;
Xu, Chun-wei
;
Lei, Lei
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/11/30
salivary duct carcinoma
tyrosine kinase inhibitor
pyrotinib
HER2 positive
targeted
©版权所有 ©2017 CSpace - Powered by
CSpace